407 related articles for article (PubMed ID: 26384446)
41. Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm.
Foote CE; Love DN; Gilkerson JR; Whalley JM
Equine Vet J; 2004 May; 36(4):341-5. PubMed ID: 15163042
[TBL] [Abstract][Full Text] [Related]
42. Investigation of the Systemic Antibody Response and Antigen Detection Following Intranasal Administration of Two Commercial Equine Herpesvirus-1 Vaccines to Adult Horses.
Spann K; Barnum S; Pusterla N
J Equine Vet Sci; 2023 Mar; 122():104229. PubMed ID: 36657628
[TBL] [Abstract][Full Text] [Related]
43. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
[TBL] [Abstract][Full Text] [Related]
44. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice.
Packiarajah P; Walker C; Gilkerson J; Whalley JM; Love DN
Vet Microbiol; 1998 Apr; 61(4):261-78. PubMed ID: 9646476
[TBL] [Abstract][Full Text] [Related]
45. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
[TBL] [Abstract][Full Text] [Related]
46. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
Patel JR; Bateman H; Williams J; Didlick S
Vet Microbiol; 2003 Jan; 91(1):23-39. PubMed ID: 12441229
[TBL] [Abstract][Full Text] [Related]
47. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
Paillot R; Daly JM; Luce R; Montesso F; Davis-Poynter N; Hannant D; Kydd JH
Dev Comp Immunol; 2007; 31(2):202-14. PubMed ID: 16824599
[TBL] [Abstract][Full Text] [Related]
48. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
[TBL] [Abstract][Full Text] [Related]
49. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
[TBL] [Abstract][Full Text] [Related]
50. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
Heldens JG; Hannant D; Cullinane AA; Prendergast MJ; Mumford JA; Nelly M; Kydd JH; Weststrate MW; van den Hoven R
Vaccine; 2001 Jul; 19(30):4307-17. PubMed ID: 11457558
[TBL] [Abstract][Full Text] [Related]
51. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
Kydd JH; Hannant D; Robinson RS; Bryant N; Osterrieder N
Vaccine; 2020 Jan; 38(2):388-398. PubMed ID: 31629571
[TBL] [Abstract][Full Text] [Related]
52. Epizootiological investigation of equine herpesvirus type 1 infection among Japanese racehorses before and after the replacement of an inactivated vaccine with a modified live vaccine.
Bannai H; Tsujimura K; Nemoto M; Ohta M; Yamanaka T; Kokado H; Matsumura T
BMC Vet Res; 2019 Aug; 15(1):280. PubMed ID: 31387602
[TBL] [Abstract][Full Text] [Related]
53. Immune and Inflammatory Response in Horse Vaccinated Against Equine Herpesviruses 1 (EHV-1) and 4 (EHV-4) Assessed by Serum Protein Electrophoretic Pattern and Leukocyte Population.
Giannetto C; Giudice E; Piccione G; Castronovo C; Arfuso F
J Equine Vet Sci; 2022 Sep; 116():104051. PubMed ID: 35753636
[TBL] [Abstract][Full Text] [Related]
54. Potential of DNA-mediated vaccination for equine herpesvirus 1.
Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
Vet Microbiol; 1999 Aug; 68(1-2):35-48. PubMed ID: 10501160
[TBL] [Abstract][Full Text] [Related]
55. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
[TBL] [Abstract][Full Text] [Related]
56. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH
Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852
[TBL] [Abstract][Full Text] [Related]
57. Equine Herpesvirus-I Infection in Horses: Recent Updates on its Pathogenicity, Vaccination, and Preventive Management Strategies.
Khusro A; Aarti C; Rivas-Caceres RR; Barbabosa-Pliego A
J Equine Vet Sci; 2020 Apr; 87():102923. PubMed ID: 32172913
[TBL] [Abstract][Full Text] [Related]
58. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
Bryans JT; Allen GP
Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
[TBL] [Abstract][Full Text] [Related]
59. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
60. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
Bürki F; Rossmanith W; Nowotny N; Pallan C; Möstl K; Lussy H
Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
